TickerStat.com

NERVGEN PHARMA CORP. (NGEN)

Price—Loading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

No reported data

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Research & development$13.9M$15.8M
Operating expenses$25.1M$25.2M
Net income−$44.1M−$24.3M
Basic EPSper diluted share-CA$0.61-CA$0.36
Diluted EPSper diluted share-CA$0.61-CA$0.36
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗